FATTY ACIDS, ESSENTIAL / OMEGA, FISH OIL / VEGETABLE OIL DIETARY SUPPLEMENTS, Doses

« »

FATTY ACIDS, ESSENTIAL / OMEGA, FISH OIL / VEGETABLE OIL DIETARY SUPPLEMENTS

↪ Doses - FATTY ACIDS, ESSENTIAL / OMEGA, FISH OIL / VEGETABLE OIL DIETARY SUPPLEMENTS Chemistry - The commercially available veterinary products generally contain a combination offish oil (eicosapentaenoic and docosahexanoic acids), vegetable oil (gamma linolenic acid) whichserve as... ↪ Read more

Doses - FAMOTIDINE

↪ Description - FAMOTIDINE Dogs: As an adjunct in ulcer treatment: a) 0.5 mg/kg PO, SubQ, IM, IV q12-24 hours (Matz 1995) b) 0.5 - 1 mg/kg PO or IV once or twice daily (Johnson, Sherding et al. 1994)Cats: As an adjunct in ulcer treatment: a) 0.5 mg/kg PO, SubQ, IM, IV q12-24 hours (Matz... ↪ Read more

FAMOTIDINE

↪ Doses - FAMOTIDINE Chemistry - An H2-receptor antagonist, famotidine occurs as a white to pale yellow, crystalline powder. It is odorless, but has a bitter taste. 740 micrograms are soluble in one ml of water.Storage, Stability, Compatibility Tablets should be stored in well-closed,... ↪ Read more

Doses - EUTHANASIA AGENTS CONTAINING PENTOBARBITAL

↪ Description - EUTHANASIA AGENTS CONTAINING PENTOBARBITAL Because different products have different concentrations, please refer to the informationprovided with the product in use.Dogs: Pentobarbital sodium (as a single agent): Approximately 120 mg/kg for the first 4.5 kgof body weight,... ↪ Read more

EUTHANASIA AGENTS CONTAINING PENTOBARBITAL

↪ Doses - EUTHANASIA AGENTS CONTAINING PENTOBARBITAL For therapeutic uses (other than euthanasia) of pentobarbital, see the main pentobarbital monographfor this agent. The sections on chemistry, storage, pharmacokinetics, overdosage, drug interactions, and monitoring parameters can be found... ↪ Read more

Doses - ETRETINATE, ACITRETIN

↪ Description - ETRETINATE, ACITRETIN Dogs: For treating seborrhea: a) In American cocker spaniels: 0.75 - 1 mg/kg PO once daily; may require long termtherapy. (Kwochka 1992) b) 1 mg/kg PO once daily (q24h); response is seen within 2 months (Kwochka 1994) For treatment of primary seborrhea... ↪ Read more

ETRETINATE, ACITRETIN

↪ Doses - ETRETINATE, ACITRETIN Note: Etretinate has recently been withdrawn from the market by its manufacturer andreplaced with acitretin. Acitretin is an active metabolite of etritinate and has the sameindications, but acitretin is reportedly dosed at a rate of 2/3's that of etrinate.... ↪ Read more

Doses - ETODOLAC

Dogs: a) For treatment of pain and inflammation associated with osteoarthritis: 10 - 15 mg/kg POonce daily. Dogs less than 5 kg cannot be accurately dosed with EtoGesic®. Adjustdose to obtain satisfactory response, but do not exceed 15 mg/kg. For long termtherapy, reduce dose level to minimum... ↪ Read more

ETODOLAC

↪ Doses - ETODOLAC Chemistry/Storage, Stability, Compatibility An indole acetic acid derivative non-steroidalantiinflammatory agent (NSAID), etodolac occurs as a white, crystalline compound that is insolublein water, but soluble in alcohol or DMSO. The commercially available veterinary... ↪ Read more

Doses - ETIDRONATE DISODIUM

↪ Description - ETIDRONATE DISODIUM Dogs: For severe hypercalcemia associated with neoplastic disease: a) 5 mg/kg/day PO (Papich 1992)Cats: For severe hypercalcemia associated with neoplastic disease: a) 10 mg/kg/day PO (Papich 1992) Monitoring Parameters - Serum calcium; serum... ↪ Read more

ETIDRONATE DISODIUM

↪ Doses - ETIDRONATE DISODIUM Chemistry - An analog of pyrophosphate, etidronate disodium (also known as EHDP, Na2EHDP, or sodium etidronate) is a biphosphonate agent that occurs as a white powder and is freely soluble in water. Unlike pyrophosphate, etidronate is resistant to enzymatic... ↪ Read more

Doses - ETHYLISOBUTRAZINE HCL

↪ Description - ETHYLISOBUTRAZINE HCL Dogs: a) 4.4 - 11 mg/kg IM or PO, or 2.2 - 4.4 mg/kg IV. Duration and degree of tranquilizationmay be varied between 6-72 hours by adjusting dosage. Young animals may requirelower dosages. When used as a preoperative medication, the general anesthetic... ↪ Read more